APO Research
Talk to an analyst

APO RESEARCH · REPORT

KI-67 Antibody

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global KI-67 Antibody Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

19 December 2025199 pages

Choose your research edition.

Industry ResearchKI-67 Antibody Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal KI-67 Antibody Industry Growth and Trends Forecast to 2032100 pages · $3,450 USDMarket StructureGlobal KI-67 Antibody Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal KI-67 Antibody Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal KI-67 Antibody Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global KI-67 Antibody market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for KI-67 Antibody is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for KI-67 Antibody is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for KI-67 Antibody is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for KI-67 Antibody is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of KI-67 Antibody include Atlas Antibodies, BD Biosciences, Beckman Coulter, Bio-Rad, FineTest, Leica Biosystems, Miltenyi Biotec, Miltenyi Biotec and NSJ Bioreagents, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global KI-67 Antibody market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of KI-67 Antibody and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents KI-67 Antibody revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the KI-67 Antibody market size, projected growth trends, production technologies, key applications, and end-use industries.

KI-67 Antibody Segment by Company

Atlas Antibodies

BD Biosciences

Beckman Coulter

Bio-Rad

FineTest

Leica Biosystems

Miltenyi Biotec

Miltenyi Biotec

NSJ Bioreagents

Proteintech

Synaptic

United States Biological

Merck

Thermo Fisher Scientific

KI-67 Antibody Segment by Type

Polyclonal

Monoclonal

KI-67 Antibody Segment by Application

Immunohistochemistry Paraffin

Immunohistochemistry Frozen

Immunofluorescence

Western Blot

Others

KI-67 Antibody Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global KI-67 Antibody market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of KI-67 Antibody and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of KI-67 Antibody.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of KI-67 Antibody in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global KI-67 Antibody industry.

Chapter 3: Detailed analysis of KI-67 Antibody companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, KI-67 Antibodyrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global KI-67 Antibody Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Polyclonal Table 3. Key Players of Monoclonal Table 4. Global KI-67 Antibody Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Immunohistochemistry Paraffin Table 6. Key Players of Immunohistochemistry Frozen Table 7. Key Players of Immunofluorescence Table 8. Key Players of Western Blot Table 9. Key Players of Others Table 10. Global KI-67 Antibody Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 11. Global KI-67 Antibody Market Size by Region (2021-2026) & (US$ Million) Table 12. Global KI-67 Antibody Market Share by Region (2021-2026) Table 13. Global KI-67 Antibody Market Size by Region (2027-2032) & (US$ Million) Table 14. Global KI-67 Antibody Market Share by Region (2027-2032) Table 15. KI-67 Antibody Industry Trends Table 16. KI-67 Antibody Industry Drivers Table 17. KI-67 Antibody Industry Opportunities and Challenges Table 18. KI-67 Antibody Industry Restraints Table 19. Global KI-67 Antibody Revenue by Company (US$ Million) & (2021-2026) Table 20. Global KI-67 Antibody Revenue Market Share by Company (2021-2026) Table 21. Global KI-67 Antibody Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 22. Global KI-67 Antibody Key Company Head Office and Area Served Table 23. Global KI-67 Antibody Company, Product Type & Application Table 24. Global KI-67 Antibody Company Establishment Date Table 25. Global Company Market Concentration Ratio (CR5 and HHI) Table 26. Global KI-67 Antibody by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 27. Global KI-67 Antibody Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global KI-67 Antibody Market Size by Type (2021-2026) & (US$ Million) Table 29. Global KI-67 Antibody Market Size by Type (2027-2032) & (US$ Million) Table 30. Global KI-67 Antibody Revenue Market Share by Type (2021-2026) Table 31. Global KI-67 Antibody Revenue Market Share by Type (2027-2032) Table 32. Global KI-67 Antibody Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global KI-67 Antibody Market Size by Application (2021-2026) & (US$ Million) Table 34. Global KI-67 Antibody Market Size by Application (2027-2032) & (US$ Million) Table 35. Global KI-67 Antibody Revenue Market Share by Application (2021-2026) Table 36. Global KI-67 Antibody Revenue Market Share by Application (2027-2032) Table 37. Atlas Antibodies Company Information Table 38. Atlas Antibodies Business Overview Table 39. Atlas Antibodies KI-67 Antibody Revenue and Gross Margin (US$ Million) & (2021-2026) Table 40. Atlas Antibodies KI-67 Antibody Product Portfolio Table 41. Atlas Antibodies Recent Development Table 42. BD Biosciences Company Information Table 43. BD Biosciences Business Overview Table 44. BD Biosciences KI-67 Antibody Revenue and Gross Margin (US$ Million) & (2021-2026) Table 45. BD Biosciences KI-67 Antibody Product Portfolio Table 46. BD Biosciences Recent Development Table 47. Beckman Coulter Company Information Table 48. Beckman Coulter Business Overview Table 49. Beckman Coulter KI-67 Antibody Revenue and Gross Margin (US$ Million) & (2021-2026) Table 50. Beckman Coulter KI-67 Antibody Product Portfolio Table 51. Beckman Coulter Recent Development Table 52. Bio-Rad Company Information Table 53. Bio-Rad Business Overview Table 54. Bio-Rad KI-67 Antibody Revenue and Gross Margin (US$ Million) & (2021-2026) Table 55. Bio-Rad KI-67 Antibody Product Portfolio Table 56. Bio-Rad Recent Development Table 57. FineTest Company Information Table 58. FineTest Business Overview Table 59. FineTest KI-67 Antibody Revenue and Gross Margin (US$ Million) & (2021-2026) Table 60. FineTest KI-67 Antibody Product Portfolio Table 61. FineTest Recent Development Table 62. Leica Biosystems Company Information Table 63. Leica Biosystems Business Overview Table 64. Leica Biosystems KI-67 Antibody Revenue and Gross Margin (US$ Million) & (2021-2026) Table 65. Leica Biosystems KI-67 Antibody Product Portfolio Table 66. Leica Biosystems Recent Development Table 67. Miltenyi Biotec Company Information Table 68. Miltenyi Biotec Business Overview Table 69. Miltenyi Biotec KI-67 Antibody Revenue and Gross Margin (US$ Million) & (2021-2026) Table 70. Miltenyi Biotec KI-67 Antibody Product Portfolio Table 71. Miltenyi Biotec Recent Development Table 72. Miltenyi Biotec Company Information Table 73. Miltenyi Biotec Business Overview Table 74. Miltenyi Biotec KI-67 Antibody Revenue and Gross Margin (US$ Million) & (2021-2026) Table 75. Miltenyi Biotec KI-67 Antibody Product Portfolio Table 76. Miltenyi Biotec Recent Development Table 77. NSJ Bioreagents Company Information Table 78. NSJ Bioreagents Business Overview Table 79. NSJ Bioreagents KI-67 Antibody Revenue and Gross Margin (US$ Million) & (2021-2026) Table 80. NSJ Bioreagents KI-67 Antibody Product Portfolio Table 81. NSJ Bioreagents Recent Development Table 82. Proteintech Company Information Table 83. Proteintech Business Overview Table 84. Proteintech KI-67 Antibody Revenue and Gross Margin (US$ Million) & (2021-2026) Table 85. Proteintech KI-67 Antibody Product Portfolio Table 86. Proteintech Recent Development Table 87. Synaptic Company Information Table 88. Synaptic Business Overview Table 89. Synaptic KI-67 Antibody Revenue and Gross Margin (US$ Million) & (2021-2026) Table 90. Synaptic KI-67 Antibody Product Portfolio Table 91. Synaptic Recent Development Table 92. United States Biological Company Information Table 93. United States Biological Business Overview Table 94. United States Biological KI-67 Antibody Revenue and Gross Margin (US$ Million) & (2021-2026) Table 95. United States Biological KI-67 Antibody Product Portfolio Table 96. United States Biological Recent Development Table 97. Merck Company Information Table 98. Merck Business Overview Table 99. Merck KI-67 Antibody Revenue and Gross Margin (US$ Million) & (2021-2026) Table 100. Merck KI-67 Antibody Product Portfolio Table 101. Merck Recent Development Table 102. Thermo Fisher Scientific Company Information Table 103. Thermo Fisher Scientific Business Overview Table 104. Thermo Fisher Scientific KI-67 Antibody Revenue and Gross Margin (US$ Million) & (2021-2026) Table 105. Thermo Fisher Scientific KI-67 Antibody Product Portfolio Table 106. Thermo Fisher Scientific Recent Development Table 107. North America KI-67 Antibody Market Size by Type (2021-2026) & (US$ Million) Table 108. North America KI-67 Antibody Market Size by Type (2027-2032) & (US$ Million) Table 109. North America KI-67 Antibody Market Size by Application (2021-2026) & (US$ Million) Table 110. North America KI-67 Antibody Market Size by Application (2027-2032) & (US$ Million) Table 111. North America KI-67 Antibody Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 112. North America KI-67 Antibody Market Size by Country (2021-2026) Table 113. North America KI-67 Antibody Market Size by Country (2027-2032) Table 114. Europe KI-67 Antibody Market Size by Type (2021-2026) & (US$ Million) Table 115. Europe KI-67 Antibody Market Size by Type (2027-2032) & (US$ Million) Table 116. Europe KI-67 Antibody Market Size by Application (2021-2026) & (US$ Million) Table 117. Europe KI-67 Antibody Market Size by Application (2027-2032) & (US$ Million) Table 118. Europe KI-67 Antibody Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 119. Europe KI-67 Antibody Market Size by Country (2021-2026) Table 120. Europe KI-67 Antibody Market Size by Country (2027-2032) Table 121. China KI-67 Antibody Market Size by Type (2021-2026) & (US$ Million) Table 122. China KI-67 Antibody Market Size by Type (2027-2032) & (US$ Million) Table 123. China KI-67 Antibody Market Size by Application (2021-2026) & (US$ Million) Table 124. China KI-67 Antibody Market Size by Application (2027-2032) & (US$ Million) Table 125. Asia KI-67 Antibody Market Size by Type (2021-2026) & (US$ Million) Table 126. Asia KI-67 Antibody Market Size by Type (2027-2032) & (US$ Million) Table 127. Asia KI-67 Antibody Market Size by Application (2021-2026) & (US$ Million) Table 128. Asia KI-67 Antibody Market Size by Application (2027-2032) & (US$ Million) Table 129. Asia KI-67 Antibody Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 130. Asia KI-67 Antibody Market Size by Country (2021-2026) Table 131. Asia KI-67 Antibody Market Size by Country (2027-2032) Table 132. South America, Middle East & Africa KI-67 Antibody Market Size by Type (2021-2026) & (US$ Million) Table 133. South America, Middle East & Africa KI-67 Antibody Market Size by Type (2027-2032) & (US$ Million) Table 134. South America, Middle East & Africa KI-67 Antibody Market Size by Application (2021-2026) & (US$ Million) Table 135. South America, Middle East & Africa KI-67 Antibody Market Size by Application (2027-2032) & (US$ Million) Table 136. South America, Middle East & Africa KI-67 Antibody Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 137. South America, Middle East & Africa KI-67 Antibody Market Size by Country (2021-2026) Table 138. South America, Middle East & Africa KI-67 Antibody Market Size by Country (2027-2032) Table 139. Research Programs/Design for This Report Table 140. Authors List of This Report Table 141. Secondary Sources Table 142. Primary Sources List of Figures Figure 1. KI-67 Antibody Product Image Figure 2. Global KI-67 Antibody Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global KI-67 Antibody Market Share by Type: 2025 VS 2032 Figure 4. Polyclonal Image Figure 5. Monoclonal Image Figure 6. Global KI-67 Antibody Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 7. Global KI-67 Antibody Market Share by Application: 2025 VS 2032 Figure 8. Immunohistochemistry Paraffin Image Figure 9. Immunohistochemistry Frozen Image Figure 10. Immunofluorescence Image Figure 11. Western Blot Image Figure 12. Others Image Figure 13. Global KI-67 Antibody Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global KI-67 Antibody Market Size (2021-2032) & (US$ Million) Figure 15. Global KI-67 Antibody Market Share by Region: 2025 VS 2032 Figure 16. Years Considered Figure 17. Global KI-67 Antibody Market Share by Players in 2025 Figure 18. Global Top 5 and 10 KI-67 Antibody Players Market Share by Revenue in 2025 Figure 19. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 20. Global KI-67 Antibody Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global KI-67 Antibody Revenue Market Share by Type (2021-2032) Figure 22. Global KI-67 Antibody Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global KI-67 Antibody Revenue Market Share by Application (2021-2032) Figure 24. North America KI-67 Antibody Market Size (2021-2032) & (US$ Million) Figure 25. North America KI-67 Antibody Market Share by Type (2021-2032) Figure 26. North America KI-67 Antibody Market Share by Application (2021-2032) Figure 27. North America KI-67 Antibody Market Share by Country (2021-2032) Figure 28. United States KI-67 Antibody Market Size (2021-2032) & (US$ Million) Figure 29. Canada KI-67 Antibody Market Size (2021-2032) & (US$ Million) Figure 30. Mexico KI-67 Antibody Market Size (2021-2032) & (US$ Million) Figure 31. Europe KI-67 Antibody Market Size (2021-2032) & (US$ Million) Figure 32. Europe KI-67 Antibody Market Share by Type (2021-2032) Figure 33. Europe KI-67 Antibody Market Share by Application (2021-2032) Figure 34. Europe KI-67 Antibody Market Share by Country (2021-2032) Figure 35. Germany KI-67 Antibody Market Size (2021-2032) & (US$ Million) Figure 36. France KI-67 Antibody Market Size (2021-2032) & (US$ Million) Figure 37. U.K. KI-67 Antibody Market Size (2021-2032) & (US$ Million) Figure 38. Italy KI-67 Antibody Market Size (2021-2032) & (US$ Million) Figure 39. Russia KI-67 Antibody Market Size (2021-2032) & (US$ Million) Figure 40. Nordic Countries KI-67 Antibody Market Size (2021-2032) & (US$ Million) Figure 41. China KI-67 Antibody Market Size (2021-2032) & (US$ Million) Figure 42. China KI-67 Antibody Market Share by Type (2021-2032) Figure 43. China KI-67 Antibody Market Share by Application (2021-2032) Figure 44. Asia KI-67 Antibody Market Size (2021-2032) & (US$ Million) Figure 45. Asia KI-67 Antibody Market Share by Type (2021-2032) Figure 46. Asia KI-67 Antibody Market Share by Application (2021-2032) Figure 47. Asia KI-67 Antibody Market Share by Country (2021-2032) Figure 48. Japan KI-67 Antibody Market Size (2021-2032) & (US$ Million) Figure 49. South Korea KI-67 Antibody Market Size (2021-2032) & (US$ Million) Figure 50. Taiwan KI-67 Antibody Market Size (2021-2032) & (US$ Million) Figure 51. Southeast Asia KI-67 Antibody Market Size (2021-2032) & (US$ Million) Figure 52. India KI-67 Antibody Market Size (2021-2032) & (US$ Million) Figure 53. Australia KI-67 Antibody Market Size (2021-2032) & (US$ Million) Figure 54. South America, Middle East & Africa KI-67 Antibody Market Size (2021-2032) & (US$ Million) Figure 55. South America, Middle East & Africa KI-67 Antibody Market Share by Type (2021-2032) Figure 56. South America, Middle East & Africa KI-67 Antibody Market Share by Application (2021-2032) Figure 57. South America, Middle East & Africa KI-67 Antibody Market Share by Country (2021-2032) Figure 58. Brazil KI-67 Antibody Market Size (2021-2032) & (US$ Million) Figure 59. South Africa KI-67 Antibody Market Size (2021-2032) & (US$ Million) Figure 60. Saudi Arabia KI-67 Antibody Market Size (2021-2032) & (US$ Million) Figure 61. Turkey KI-67 Antibody Market Size (2021-2032) & (US$ Million) Figure 62. Argentina KI-67 Antibody Market Size (2021-2032) & (US$ Million) Figure 63. UAE KI-67 Antibody Market Size (2021-2032) & (US$ Million) Figure 64. Egypt KI-67 Antibody Market Size (2021-2032) & (US$ Million) Figure 65. Chile KI-67 Antibody Market Size (2021-2032) & (US$ Million) Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • Polyclonal
  • Monoclonal
Applications
  • Immunohistochemistry Paraffin
  • Immunohistochemistry Frozen
  • Immunofluorescence
  • Western Blot
  • Others
Companies covered
  • Atlas Antibodies
  • BD Biosciences
  • Beckman Coulter
  • Bio-Rad
  • FineTest
  • Leica Biosystems
  • Miltenyi Biotec
  • Miltenyi Biotec
  • NSJ Bioreagents
  • Proteintech
  • Synaptic
  • United States Biological
  • Merck
  • Thermo Fisher Scientific

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global KI-67 Antibody Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Polyclonal
  5. 1.2.3 Monoclonal
  6. 1.3 Market Analysis by Application
  7. 1.3.1 Global KI-67 Antibody Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  8. 1.3.2 Immunohistochemistry Paraffin
  9. 1.3.3 Immunohistochemistry Frozen
  10. 1.3.4 Immunofluorescence
  11. 1.3.5 Western Blot
  12. 1.3.6 Others
  13. 1.4 Global Market Growth Prospects
  14. 1.5 Global KI-67 Antibody Growth Trends by Region
  15. 1.5.1 Global KI-67 Antibody Market Size by Region: 2021 VS 2025 VS 2032
  16. 1.5.2 KI-67 Antibody Market Size by Region (2021-2026)
  17. 1.5.3 KI-67 Antibody Market Size by Region (2027-2032)
  18. 1.6 Assumptions and Limitations
  19. 1.7 Study Goals and Objectives
  20. 1.8 Years Considered
2 Global KI-67 Antibody Market Dynamics
  1. 2.1 KI-67 Antibody Industry Trends
  2. 2.2 KI-67 Antibody Industry Drivers
  3. 2.3 KI-67 Antibody Industry Opportunities and Challenges
  4. 2.4 KI-67 Antibody Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global KI-67 Antibody Revenue by Company (2021-2026)
  2. 3.2 Global KI-67 Antibody Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global KI-67 Antibody Key Company Head office and Area Served
  4. 3.4 Global KI-67 Antibody Company, Product Type & Application
  5. 3.5 Global KI-67 Antibody Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global KI-67 Antibody Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 KI-67 Antibody Players Market Share by Revenue in 2025
  9. 3.6.3 2025 KI-67 Antibody Tier 1, Tier 2, and Tier 3
4 KI-67 Antibody Market by Type
  1. 4.1 Global KI-67 Antibody Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global KI-67 Antibody Market Size by Type (2021-2032)
  3. 4.3 Global KI-67 Antibody Market Size Share by Type (2021-2032)
5 KI-67 Antibody Market by Application
  1. 5.1 Global KI-67 Antibody Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global KI-67 Antibody Market Size by Application (2021-2032)
  3. 5.3 Global KI-67 Antibody Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Atlas Antibodies
  2. 6.1.1 Atlas Antibodies Company Information
  3. 6.1.2 Atlas Antibodies Business Overview
  4. 6.1.3 Atlas Antibodies KI-67 Antibody Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Atlas Antibodies KI-67 Antibody Product Portfolio
  6. 6.1.5 Atlas Antibodies Recent Developments
  7. 6.2 BD Biosciences
  8. 6.2.1 BD Biosciences Company Information
  9. 6.2.2 BD Biosciences Business Overview
  10. 6.2.3 BD Biosciences KI-67 Antibody Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 BD Biosciences KI-67 Antibody Product Portfolio
  12. 6.2.5 BD Biosciences Recent Developments
  13. 6.3 Beckman Coulter
  14. 6.3.1 Beckman Coulter Company Information
  15. 6.3.2 Beckman Coulter Business Overview
  16. 6.3.3 Beckman Coulter KI-67 Antibody Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Beckman Coulter KI-67 Antibody Product Portfolio
  18. 6.3.5 Beckman Coulter Recent Developments
  19. 6.4 Bio-Rad
  20. 6.4.1 Bio-Rad Company Information
  21. 6.4.2 Bio-Rad Business Overview
  22. 6.4.3 Bio-Rad KI-67 Antibody Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Bio-Rad KI-67 Antibody Product Portfolio
  24. 6.4.5 Bio-Rad Recent Developments
  25. 6.5 FineTest
  26. 6.5.1 FineTest Company Information
  27. 6.5.2 FineTest Business Overview
  28. 6.5.3 FineTest KI-67 Antibody Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 FineTest KI-67 Antibody Product Portfolio
  30. 6.5.5 FineTest Recent Developments
  31. 6.6 Leica Biosystems
  32. 6.6.1 Leica Biosystems Company Information
  33. 6.6.2 Leica Biosystems Business Overview
  34. 6.6.3 Leica Biosystems KI-67 Antibody Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Leica Biosystems KI-67 Antibody Product Portfolio
  36. 6.6.5 Leica Biosystems Recent Developments
  37. 6.7 Miltenyi Biotec
  38. 6.7.1 Miltenyi Biotec Company Information
  39. 6.7.2 Miltenyi Biotec Business Overview
  40. 6.7.3 Miltenyi Biotec KI-67 Antibody Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 Miltenyi Biotec KI-67 Antibody Product Portfolio
  42. 6.7.5 Miltenyi Biotec Recent Developments
  43. 6.8 Miltenyi Biotec
  44. 6.8.1 Miltenyi Biotec Company Information
  45. 6.8.2 Miltenyi Biotec Business Overview
  46. 6.8.3 Miltenyi Biotec KI-67 Antibody Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 Miltenyi Biotec KI-67 Antibody Product Portfolio
  48. 6.8.5 Miltenyi Biotec Recent Developments
  49. 6.9 NSJ Bioreagents
  50. 6.9.1 NSJ Bioreagents Company Information
  51. 6.9.2 NSJ Bioreagents Business Overview
  52. 6.9.3 NSJ Bioreagents KI-67 Antibody Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 NSJ Bioreagents KI-67 Antibody Product Portfolio
  54. 6.9.5 NSJ Bioreagents Recent Developments
  55. 6.10 Proteintech
  56. 6.10.1 Proteintech Company Information
  57. 6.10.2 Proteintech Business Overview
  58. 6.10.3 Proteintech KI-67 Antibody Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 Proteintech KI-67 Antibody Product Portfolio
  60. 6.10.5 Proteintech Recent Developments
  61. 6.11 Synaptic
  62. 6.11.1 Synaptic Company Information
  63. 6.11.2 Synaptic Business Overview
  64. 6.11.3 Synaptic KI-67 Antibody Revenue and Gross Margin (US$ Million) & (2021-2026)
  65. 6.11.4 Synaptic KI-67 Antibody Product Portfolio
  66. 6.11.5 Synaptic Recent Developments
  67. 6.12 United States Biological
  68. 6.12.1 United States Biological Company Information
  69. 6.12.2 United States Biological Business Overview
  70. 6.12.3 United States Biological KI-67 Antibody Revenue and Gross Margin (US$ Million) & (2021-2026)
  71. 6.12.4 United States Biological KI-67 Antibody Product Portfolio
  72. 6.12.5 United States Biological Recent Developments
  73. 6.13 Merck
  74. 6.13.1 Merck Company Information
  75. 6.13.2 Merck Business Overview
  76. 6.13.3 Merck KI-67 Antibody Revenue and Gross Margin (US$ Million) & (2021-2026)
  77. 6.13.4 Merck KI-67 Antibody Product Portfolio
  78. 6.13.5 Merck Recent Developments
  79. 6.14 Thermo Fisher Scientific
  80. 6.14.1 Thermo Fisher Scientific Company Information
  81. 6.14.2 Thermo Fisher Scientific Business Overview
  82. 6.14.3 Thermo Fisher Scientific KI-67 Antibody Revenue and Gross Margin (US$ Million) & (2021-2026)
  83. 6.14.4 Thermo Fisher Scientific KI-67 Antibody Product Portfolio
  84. 6.14.5 Thermo Fisher Scientific Recent Developments
7 North America
  1. 7.1 North America KI-67 Antibody Market Size (2021-2032)
  2. 7.2 North America KI-67 Antibody Market Size by Type
  3. 7.2.1 North America KI-67 Antibody Market Size by Type (2021-2026)
  4. 7.2.2 North America KI-67 Antibody Market Size by Type (2027-2032)
  5. 7.2.3 North America KI-67 Antibody Market Share by Type (2021-2032)
  6. 7.3 North America KI-67 Antibody Market Size by Application
  7. 7.3.1 North America KI-67 Antibody Market Size by Application (2021-2026)
  8. 7.3.2 North America KI-67 Antibody Market Size by Application (2027-2032)
  9. 7.3.3 North America KI-67 Antibody Market Share by Application (2021-2032)
  10. 7.4 North America KI-67 Antibody Market Size by Country
  11. 7.4.1 North America KI-67 Antibody Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America KI-67 Antibody Market Size by Country (2021-2026)
  13. 7.4.3 North America KI-67 Antibody Market Size by Country (2027-2032)
  14. 7.4.4 North America KI-67 Antibody Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe KI-67 Antibody Market Size (2021-2032)
  2. 8.2 Europe KI-67 Antibody Market Size by Type
  3. 8.2.1 Europe KI-67 Antibody Market Size by Type (2021-2026)
  4. 8.2.2 Europe KI-67 Antibody Market Size by Type (2027-2032)
  5. 8.2.3 Europe KI-67 Antibody Market Share by Type (2021-2032)
  6. 8.3 Europe KI-67 Antibody Market Size by Application
  7. 8.3.1 Europe KI-67 Antibody Market Size by Application (2021-2026)
  8. 8.3.2 Europe KI-67 Antibody Market Size by Application (2027-2032)
  9. 8.3.3 Europe KI-67 Antibody Market Share by Application (2021-2032)
  10. 8.4 Europe KI-67 Antibody Market Size by Country
  11. 8.4.1 Europe KI-67 Antibody Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe KI-67 Antibody Market Size by Country (2021-2026)
  13. 8.4.3 Europe KI-67 Antibody Market Size by Country (2027-2032)
  14. 8.4.4 Europe KI-67 Antibody Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China KI-67 Antibody Market Size (2021-2032)
  2. 9.2 China KI-67 Antibody Market Size by Type
  3. 9.2.1 China KI-67 Antibody Market Size by Type (2021-2026)
  4. 9.2.2 China KI-67 Antibody Market Size by Type (2027-2032)
  5. 9.2.3 China KI-67 Antibody Market Share by Type (2021-2032)
  6. 9.3 China KI-67 Antibody Market Size by Application
  7. 9.3.1 China KI-67 Antibody Market Size by Application (2021-2026)
  8. 9.3.2 China KI-67 Antibody Market Size by Application (2027-2032)
  9. 9.3.3 China KI-67 Antibody Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia KI-67 Antibody Market Size (2021-2032)
  2. 10.2 Asia KI-67 Antibody Market Size by Type
  3. 10.2.1 Asia KI-67 Antibody Market Size by Type (2021-2026)
  4. 10.2.2 Asia KI-67 Antibody Market Size by Type (2027-2032)
  5. 10.2.3 Asia KI-67 Antibody Market Share by Type (2021-2032)
  6. 10.3 Asia KI-67 Antibody Market Size by Application
  7. 10.3.1 Asia KI-67 Antibody Market Size by Application (2021-2026)
  8. 10.3.2 Asia KI-67 Antibody Market Size by Application (2027-2032)
  9. 10.3.3 Asia KI-67 Antibody Market Share by Application (2021-2032)
  10. 10.4 Asia KI-67 Antibody Market Size by Country
  11. 10.4.1 Asia KI-67 Antibody Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia KI-67 Antibody Market Size by Country (2021-2026)
  13. 10.4.3 Asia KI-67 Antibody Market Size by Country (2027-2032)
  14. 10.4.4 Asia KI-67 Antibody Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa KI-67 Antibody Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa KI-67 Antibody Market Size by Type
  3. 11.2.1 South America, Middle East & Africa KI-67 Antibody Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa KI-67 Antibody Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa KI-67 Antibody Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa KI-67 Antibody Market Size by Application
  7. 11.3.1 South America, Middle East & Africa KI-67 Antibody Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa KI-67 Antibody Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa KI-67 Antibody Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa KI-67 Antibody Market Size by Country
  11. 11.4.1 South America, Middle East & Africa KI-67 Antibody Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa KI-67 Antibody Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa KI-67 Antibody Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa KI-67 Antibody Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst